Details for 2009731612

Up to date per 13.05.2026

Actions

Title / Product Name

Kristalline (6R,7R)-7-{2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1'-tert- butoxycarbonyl-2-oxo-[1,3]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2- carboxylsäure-benzhydrylester, seine Herstellung und Verwendung

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2009731612

EP Publication Number

2268648

E-Number

558048

Language

PCT Number

EP09054405

Publication Date

05.01.2011 A

16.05.2012 B1

Registration Date

16.05.2012

AT Publication Date

15.06.2012

Application Date

14.04.2009

Registration Number

Priorities

15.04.2008

08154517

IPC

C07D 501/12 20060101AFI20091106BHEP

Maximum Duration of Protection

14.04.2029

Owner

Basilea Pharmaceutica International AG, AllschwilHegenheimermattweg 167b4058 BaselCH

Representative

Dr. Müllner Dipl.-Ing. Katschinka OG, PatentanwaltskanzleiWeihburggasse 91010 WienAT

Inventor

ALPEGIANI, MarcoVia Tolmezzo 12/5 I-20132 MilanoIT

CABRI, WalterVia Pisacane 5 I-20089 RozzanoIT

HEUBES, MarkusDrosselweg 3 79650 SchopfheimDE

LONGONI, DavideVia Di Vittorio 11 I-20064 GorgonzolaIT

SCHLEIMER, MichaelSteinenweg 17 79594 InzlingenDE

Information about Fees